A 12-year-old boy presented with a history of fever for one and a half months. On performing an examination, he had pulse rate of 90/min, respiratory rate of 20/min, and blood pressure of 110/70 mmHg; all peripheral pulses were equally palpable, pallor was noticed, and a bruit was heard in the bilateral carotid region. Examinations of the eyes revealed unremarkable findings. Laboratory investigations revealed anemia, a high erythrocyte sedimentation rate, and elevated C-reactive protein levels; work-up for infective causes was negative ([Table 1](#t1-ejr-5-4-287){ref-type="table"}). Doppler ultrasound revealed thickening of the internal lamina of the left common carotid artery, dilatation (1.2 cm), and a small saccular outpouching (8 mm) of the superior mesenteric artery (SMA) near its origin. Contrast-enhanced computed tomography angiography of the abdominal vessels revealed diffuse irregular and non-calcified mural thickening, vascular dilatation, and multiple small saccular aneurysms involving the abdominal aorta, proximal SMA, and proximal parts of the bilateral renal arteries ([Figure 1](#f1-ejr-5-4-287){ref-type="fig"}, [2](#f2-ejr-5-4-287){ref-type="fig"}). Computed tomography and corresponding fluorodeoxyglucose positron emission tomography images revealed mural thickening of the proximal left subclavian artery, brachiocephalic artery, dilated abdominal aorta, bilateral proximal renal arteries, and proximal SMA ([Figure 3](#f3-ejr-5-4-287){ref-type="fig"}[](#f4-ejr-5-4-287){ref-type="fig"}[](#f5-ejr-5-4-287){ref-type="fig"}--[6](#f6-ejr-5-4-287){ref-type="fig"}). The boy was diagnosed as having Takayasu arteritis (TA) based on the European League Against Rheumatism / Paediatric Rheumatology International Trials Organisation / Paediatric Rheumatology European Society classification criteria for childhood TA ([@b1-ejr-5-4-287]). He was initiated on injections of methylprednisolone (30 mg/kg/day) that led to prompt defervescence. He was given five pulse doses of methylprednisolone and was subsequently initiated on oral prednisolone (2 mg/kg/day). He was also initiated on monthly pulse cyclophosphamide (500 mg/m^2^, total of six pulses). During his follow-up visits for the last 8 months, he continued to be afebrile; the bruit in the carotid region disappeared, blood pressure was normal, and all pulses were equally palpable. At present, he is on tapering doses of prednisolone and azathioprine (2 mg/kg/day).

Takayasu arteritis is a chronic inflammatory disease of the aorta and its major branches. The natural course of Takayasu arteritis consists of two phases: an initial acute phase that represents the phase of inflammation, resulting in constitutional symptoms, and a second phase of vascular insufficiency, leading to symptoms such as claudication and diminished pulses. Studies on pediatric TA cases from India and USA have reported that hypertension and headache are the most common presenting manifestations ([@b2-ejr-5-4-287]--[@b4-ejr-5-4-287]). The index case had fever as the sole clinical presentation and had no signs of vascular insufficiency. Fever has been reported in approximately 4--45% of children with TA; however, fever as the only clinical presentation of TA in children is extremely uncommon ([@b2-ejr-5-4-287]--[@b4-ejr-5-4-287]).

Stenosis of large vessels is the most common angiographic abnormality associated with TA ([@b5-ejr-5-4-287]). Aneurysms have been reported in approximately 19--65% of children with TA ([@b6-ejr-5-4-287]). Aneurysms as the only angiographic abnormality of TA without stenosis or occlusion are extremely uncommon ([@b7-ejr-5-4-287]--[@b8-ejr-5-4-287]).
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![Contrast-enhanced computed tomography of the abdominal vessels shows dilatation of the abdominal aorta near the origin of the proximal superior mesenteric artery (black arrow) and small saccular aneurysms at the proximal parts of the bilateral renal arteries (white arrow)](EJR-5-4-287-g01){#f1-ejr-5-4-287}

![Transverse cuts of contrast enhanced computed tomography of the abdominal vessels show multiple aneurysms at the origin of the renal arteries (arrow)](EJR-5-4-287-g02){#f2-ejr-5-4-287}

![Fluorodeoxyglucose (FDG) positron emission tomography images at the thoracic level show FDG uptake (SUVmax: 1.9) at the thickened wall of the dilated brachiocephalic artery](EJR-5-4-287-03){#f3-ejr-5-4-287}

![Fluorodeoxyglucose (FDG) positron emission tomography images show FDG uptake (SUVmax: 1.5) at the thickened wall of the dilated left subclavian artery](EJR-5-4-287-g04){#f4-ejr-5-4-287}

![Fluorodeoxyglucose (FDG) positron emission tomography trans-axial images at the abdominal level show FDG uptake at the thickened wall of the dilated abdominal aorta and superior mesenteric artery \[SUVmax: 2.8 at the abdominal aorta (arrow) and 2.2 at the superior mesenteric artery\]](EJR-5-4-287-g05){#f5-ejr-5-4-287}

![Fluorodeoxyglucose (FDG) positron emission tomography coronal images at the abdominal level show FDG uptake (SUVmax: 1.9) at the thickened wall of the proximal renal arteries](EJR-5-4-287-g06){#f6-ejr-5-4-287}

###### 

Laboratory investigations

  Investigation                           Result
  --------------------------------------- --------------
  Hemoglobin level (gm/L)                 84
  White blood cell count (×109 cells/L)   91.8
  Differential count (N/L/M/E)            82/10/04/03
  Platelet counts (×109/L)                142
  ESR (mm in the 1st hour)                79
  CRP (mg/L) (N \< 6)                     86
  Tuberculin skin test                    0 mm
  Blood culture                           
  Urine culture                           Sterile
  Sterile                                 
  Serum Widal titers                      Non-reactive
  IgM EBV-VCA                             Non-reactive
  HIV serology                            Non-reactive
  HBsAg, Anti-HCV                         Non-reactive
  VDRL test                               Non-reactive
  2-dimensional echocardiography          Normal

CRP: C-reactive protein; EBV-VCA: Epstein Barr Virus-viral capsid antigen; ESR: erythrocyte sedimentation rate; HBsAg: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus; N/L/M/E: neutrophils/lymphocytes/monocytes/eosinophils; VDRL: venereal disease research laboratory
